Insmed Incorporated

This program provides early access to brensocatib for adults with non-cystic fibrosis bronchiectasis who completed a previous clinical trial. Participants take a daily tablet to help control their chronic lung condition. The goal is to continue managing the disease while the trea…

This study follows patients with pulmonary arterial hypertension (PAH) who continue taking an experimental inhaled powder medication called treprostinil palmitil. The main goal is to check the long-term safety and side effects of this treatment. Researchers will also monitor whet…

This study aims to check the long-term safety of an inhaled powder called TPIP for people with high blood pressure in the lungs linked to lung scarring (PH-ILD). It is open only to people who finished a previous related study. Researchers will monitor side effects and see if the …

This study is testing whether an oral drug called brensocatib can reduce painful lumps and abscesses in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease. About 214 participants will receive either the drug or a placebo for 16 weeks to s…